1-3
2026
影响因子区间
—
平台估算
44%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.
【译文】生物标志物是生理或疾病过程的物理、功能或生化指标。这些关键指标可以在确定疾病预后、预测对治疗的反应、不良事件和药物相互作用以及建立基线风险方面提供关键信息。对生物标志物研究的兴趣激增正在推动现代医疗实践中新的预测、诊断和预后产品的开发,生物标志物在发现和开发新药中也发挥着越来越重要的作用。为了充分发挥生物标志物的效用,我们需要更深入地了解疾病机制,以及疾病机制、治疗干预和拟议中的生物标志物之间的相互作用。然而,在试图系统地评估生物标志物的利弊时,我们正在进入新的、具有挑战性的领域。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |